| Background:Morbid Obesity (MO) is known as a chronic disease which has an increasing incidence worldwide. Bariatric surgery now is considered as the most effective way to the remission of MO. Among them, the Lapraroscopic Sleeve Gastrectomy is the most widely used treatment. LSG, which was designed as a first-stage procedure of MO patients initially, now is proved to result in sustained weight loss and improved the obesity-related co-morbidities such as T2DM, hypertension and dyslipidemia. Now, LSG has become a standalone procedure, and is widely acknowledged with its simplicity and efficiency.This research summarizes the clinical data of 5 MO patients who underwent LSG during Dec 2006 to Nov 2014 in Department of General Surgery of Qilu Hospital. We analyze the variation of weight loss and remission of comorbidities after the LSG, and evaluate the clinical application and efficiency of LSG.Objectives:To observe the weight, BMI index, waist and hip circumference pre-and post-operation, in order to evaluate the feasibility and safety of LSG. To discuss the techniques of LSG procedure.Methods:Clinical data of 5 MO patients were analyzed retrospectively, including 2 males and 3 females, (30.2 ± 7.6) years of age, height (169.2 ± 8.9) cm, weight (141.4 ±29.1)kg, and BMI (49.2 ± 9.0) kg/m2, waist circumference (136.8±25.5) cm; hip circumference (144.8 ± 15.9) cm; waist-hip ratio was (0.95 ± 0.17). All patients were excluded the secondary obesity by system inspection, and underwent the LSG during intravenous anesthesia and recorded the results at preoperatively and the 1st,3rd, and 6 months postoperatively. Each set of data are the mean ± standard deviation, and we apply the SPSS 20.0 statistical analysis software to analyze each set of data. There is a significant statistic difference when the P value<0.05.Results:All 5 patients were successfully carried out of LSG surgery. The operative time was (204.0 ±51.4) min, blood loss (39.4 ± 16.3) ml, postoperative hospital stay (7.6±2.2) d, postoperative gastrointestinal function recovery (1.6 ± 0.5) d.2 patients transmit to ICU after surgery and apply mechanic ventilation. No bleeding, anastomotic leakage, anastomotic stenosis, gastroparesis and other complications were found. There were no deaths. Weight at 1 month postoperatively (126.8 ± 25.2) kg (P>0.05); BMI (44.1 ±7.4) kg/m2,(P>0.05); Weight at 3 months postoperatively (111.6 ± 20.8) kg (P>0.05); BMI (39.0 ±7.1) kg/m2 (P>0.05); Weight at 6 month postoperatively (96.8 ± 14.5) kg (P<0.05); BMI (33.8 ± 5.0) kg/m2,(P<0.05). Patients with hypertension, fat-liver, T2DM have different degrees of remission and improvement.Conclusions:LSG is a safe and feasible procedure of curing the MO patients. And LSG also has the remission of comorbidities of MO, such as T2DM, hypertension and so on. LSG procedure has the advantages of simplicity and efficiency. |
PDF Full Text Request